Manhattan Psychiatric Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Schizophrenia3 trials

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial
• Manhattan Psychiatric Center1 trial
• New York State Psychiatric Institute1 trial

Running trials

• Recruiting

  A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

  NCT07434479· Manhattan Psychiatric Center· Source

• Recruiting

  Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

  NCT05208190· Phase 4· New York State Psychiatric Institute· Source

  Contact: Jean-Pierre Lindenmayer, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia2 recruiting

Closed trials

• Completed

  A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

  NCT05145413· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source